W. Mehnert

10.6k total citations · 3 hit papers
58 papers, 8.3k citations indexed

About

W. Mehnert is a scholar working on Pharmaceutical Science, Molecular Biology and Organic Chemistry. According to data from OpenAlex, W. Mehnert has authored 58 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pharmaceutical Science, 29 papers in Molecular Biology and 12 papers in Organic Chemistry. Recurrent topics in W. Mehnert's work include Advancements in Transdermal Drug Delivery (26 papers), Lipid Membrane Structure and Behavior (22 papers) and Dermatology and Skin Diseases (10 papers). W. Mehnert is often cited by papers focused on Advancements in Transdermal Drug Delivery (26 papers), Lipid Membrane Structure and Behavior (22 papers) and Dermatology and Skin Diseases (10 papers). W. Mehnert collaborates with scholars based in Germany and Italy. W. Mehnert's co-authors include Karsten Mäder, A. zur Mühlen, Monika Schäfer‐Korting, Rainer Müller, Hans Christian Körting, Eliana B. Souto, R.H. Müller, K.D. Kramer, Heike Bunjes and Christoph Johann and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

W. Mehnert

58 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Solid lipid nanoparticles Production, characterization and applications

2001 2.5k citations W. Mehnert Advanced Drug Delivery Reviews profile →
Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism

1998 747 citations A. zur Mühlen, W. Mehnert et al. European Journal of Pharmaceutics and Biopharmaceutics profile →
Solid lipid nanoparticles

2012 680 citations W. Mehnert, Karsten Mäder Advanced Drug Delivery Reviews profile →

Peers

W. Mehnert

BIOMA

DERMA

S. A. Wissing Germany

Anna Maria Fadda Italy

Om Prakash Katare India

Monika Schäfer‐Korting Germany

Vandana Patravale India

Cornelia M. Keck Germany

Yasmin Sultana India

Chiara Sinico Italy

Alfred Fahr Germany

Christel C. Müller‐Goymann Germany

S. A. Wissing Germany

W. Mehnert

4.6k ×0.8

2.1k ×0.6

2.1k ×1.0

750 ×0.7

BIOMA

1.2k ×1.1

DERMA

Citations per year, relative to W. Mehnert W. Mehnert (= 1×) peers S. A. Wissing

Countries citing papers authored by W. Mehnert

Since Specialization

Citations

This map shows the geographic impact of W. Mehnert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Mehnert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Mehnert more than expected).

Fields of papers citing papers by W. Mehnert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Mehnert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Mehnert. The network helps show where W. Mehnert may publish in the future.

Co-authorship network of co-authors of W. Mehnert

This figure shows the co-authorship network connecting the top 25 collaborators of W. Mehnert. A scholar is included among the top collaborators of W. Mehnert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Mehnert. W. Mehnert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laue, C., Christian Zoschke, W. Mehnert, et al.. (2014). Improving Topical Non-Melanoma Skin Cancer Treatment: In vitro Efficacy of a Novel Guanosine-Analog Phosphonate. Skin Pharmacology and Physiology. 27(4). 173–173. 8 indexed citations

Schlupp, Peggy, Tobias Blaschke, K.D. Kramer, et al.. (2011). Drug Release and Skin Penetration from Solid Lipid Nanoparticles and a Base Cream: A Systematic Approach from a Comparison of Three Glucocorticoids. Skin Pharmacology and Physiology. 24(4). 199–209. 63 indexed citations

Blaschke, Tobias, W.M. Herrmann, Peggy Schlupp, et al.. (2007). Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance. Journal of Controlled Release. 119(1). 128–135. 33 indexed citations

Borgia, S. Lombardi, Peggy Schlupp, W. Mehnert, & Monika Schäfer‐Korting. (2007). In vitro skin absorption and drug release – A comparison of six commercial prednicarbate preparations for topical use. European Journal of Pharmaceutics and Biopharmaceutics. 68(2). 380–389. 46 indexed citations

Schäfer‐Korting, Monika, W. Mehnert, & Hans Christian Körting. (2007). Lipid nanoparticles for improved topical application of drugs for skin diseases☆. Advanced Drug Delivery Reviews. 59(6). 427–443. 471 indexed citations

Müller, Rainer, et al.. (2006). Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals. International Journal of Pharmaceutics. 317(1). 82–89. 249 indexed citations

Souto, Eliana B., W. Mehnert, & Rainer Müller. (2006). Polymorphic behaviour of Compritol®888 ATO as bulk lipid and as SLN and NLC. Journal of Microencapsulation. 23(4). 417–433. 174 indexed citations

Haberland, Annekathrin, et al.. (2005). Solid Lipid Nanoparticles (SLN) and Oil-Loaded SLN Studied by Spectrofluorometry and Raman Spectroscopy. Pharmaceutical Research. 22(11). 1887–1897. 111 indexed citations

Borgia, S. Lombardi, Sivaramakrishnan Rajaraman, W. Mehnert, et al.. (2005). Lipid nanoparticles for skin penetration enhancement—correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. Journal of Controlled Release. 110(1). 151–163. 188 indexed citations

10.

Mehnert, W., et al.. (2004). Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. Journal of Controlled Release. 95(2). 217–227. 331 indexed citations

11.

Rajaraman, Sivaramakrishnan, Chié Nakamura, W. Mehnert, et al.. (2004). Glucocorticoid entrapment into lipid carriers — characterisation by parelectric spectroscopy and influence on dermal uptake. Journal of Controlled Release. 97(3). 493–502. 100 indexed citations

12.

Mehnert, W., et al.. (2003). Physicochemical Investigations on Solid Lipid Nanoparticles and on Oil-Loaded Solid Lipid Nanoparticles: A Nuclear Magnetic Resonance and Electron Spin Resonance Study. Pharmaceutical Research. 20(8). 1274–1283. 140 indexed citations

13.

Mehnert, W., Martin Schaller, Hans Christian Körting, et al.. (2002). Drug Targeting by Solid Lipid Nanoparticles for Dermal Use. Journal of drug targeting. 10(6). 489–495. 136 indexed citations

14.

Mehnert, W.. (2001). Solid lipid nanoparticles Production, characterization and applications. Advanced Drug Delivery Reviews. 47(2-3). 165–196. 2490 indexed citations breakdown →

15.

Eder, Michael & W. Mehnert. (2000). Pflanzliche Begleitstoffe — wertvolle Hilfsstoffe oder überflüssiger Ballast?. Pharmazie in unserer Zeit. 29(6). 377–384. 6 indexed citations

16.

Mühlen, A. zur, et al.. (1998). Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanism. European Journal of Pharmaceutics and Biopharmaceutics. 45(2). 149–155. 747 indexed citations breakdown →

17.

Mehnert, W., et al.. (1997). Solid Lipid Nanoparticles - ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika 2. Mitteilung: Wirkstoff-Inkorporation, Freisetzung und Sterilisierbarkeit. 59(6). 511–514. 23 indexed citations

18.

Müller, Rainer, et al.. (1997). Solid Lipid Nanoparticles : ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika. 1. Mitteilung: Systemeigenschaften, Herstellung und Scaling-up. 59(5). 423–427. 19 indexed citations

19.

Müller, Rainer, et al.. (1997). Solid lipid nanoparticles : ein neuartiger Wirkstoff-Carrier für Kosmetika und Pharmazeutika. 3. Mitteilung: Langzeitstabilität, Gefrier- und Sprühtrocknung, Toxizität, Anwendung in Kosmetika und Pharmazeutika. 59(7). 614–619. 11 indexed citations

20.

Müller, R.H., et al.. (1995). Solid lipid nanoparticles (SLN) : an alternative colloidal carrier system for controlled drug delivery. European Journal of Pharmaceutics and Biopharmaceutics. 41(1). 62–69. 375 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact